Official US Government Icon

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure Site Icon

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

General

Legacy ID
1

Pipeline Safety Program Reviews

In the aftermaths of the natural gas pipeline explosion and fire in San Bruno, California on September 9, 2010, and the hazardous liquid pipeline rupture in Marshall, Michigan on July 25, 2010, the National Transportation Safety Board (NTSB) formally recommended that the...

DOT FY15 SCI Analysis Plan

This document is the DOT FY15 SCI Analysis Plan.  For more information, contact Diane Morrison @ 202-366-4960 or diane.morrison@dot.gov.

DOT FY14 SCI Analysis Report

This document is the DOT FY14 SCI Analysis Report.  For more information, contact Diane Morrison @ 202-366-4960 or diane.morrison@dot.gov.

FY 2015 DOT SCI Supplemental Data

This document is the FY 2015 DOT SCI Supplemental Data.  For more information, contact Diane Morrison @ 202-366-4960 or diane.morrison@dot.gov.

DOT FY15 Appendix C Summary

This document is the DOT FY 2015 Appendix C Summary.  For more information, contact Diane Morrison @ 202-366-4960 or diane.morrison@dot.gov.

DOT Rule 49 CFR Part 40 Section 40.155

Subpart G - Medical Review Officers and the Verification Process

§ 40.155 What does the MRO do when a negative or positive test result is also dilute?

(a) When the laboratory reports that a specimen is dilute, you must, as the MRO, report to the DER that the specimen, in addition to being...

DOT Rule 49 CFR Part 40 Section 40.153

Subpart G - Medical Review Officers and the Verification Process § 40.153 How does the MRO notify employees of their right to a test of the split specimen?

(a) As the MRO, when you have verified a drug test as positive for a drug or drug metabolite, or as a refusal to test because of...